Current investments

We have one or more companies open for investments. Please login or create an account to learn more and invest.

Completed investments

Single Technologies

The company has developed a DNA sequencing solution with significantly improved performance compared with current alternatives. The market is growing rapidly in terms of both research and clinical applications.

Likvor

Likvor offers a CE-certified system helping healthcare personnel to diagnose normal pressure hydrocephalus (NPH) which is a very under diagnosed condition with dementia-like symptoms.

EMPE Diagnostics

Each year, more than 10 million people suffer from tuberculosis. EMPE has developed a patented quick test for the diagnosis of tuberculosis adapted to clinics with limited resources.

Read more

1928 Diagnostics

1928 Diagnostics is fighting against the global threat of resistant bacteria by offering software for the quick and effective diagnose of bacterial infections. The software is offered as a software-as-a-service and in combination with hardware already used in hospitals it provided detailed information regarding bacteria and their resistance profiles.

Exits

Learning to Sleep

Learning to Sleep is a digital sleep clinic. The company offers an evidence-based treatment that uniquely combines support from a sleep coach with digital aids.

Read more

Cartana

Cartana’s patent-applied research tool revolutionizes the possibility of analyzing tissue samples, providing pharmaceutical companies with important information in their quest for new treatments.

Read more

Inhalation Sciences

Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.

Read more

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Read more